Semi-Annual Statement Of Income And Retained Earnings

Daito Pharmaceutical Co., Ltd. - Filing #7720498

Concept 2017-06-01 to
2018-05-31
2017-06-01 to
2018-05-31
2017-06-01 to
2018-05-31
2017-06-01 to
2018-05-31
2017-06-01 to
2018-05-31
2016-06-01 to
2017-05-31
2016-06-01 to
2017-05-31
2016-06-01 to
2017-05-31
2016-06-01 to
2017-05-31
2016-06-01 to
2017-05-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
4,161,156,000 JPY
3,770,932,000 JPY
3,832,165,000 JPY
3,123,920,000 JPY
Non-operating income
Non-operating income
125,343,000 JPY
215,671,000 JPY
169,270,000 JPY
156,480,000 JPY
Non-operating expenses
Non-operating expenses
42,472,000 JPY
41,595,000 JPY
122,607,000 JPY
112,990,000 JPY
Ordinary profit (loss)
4,244,028,000 JPY
3,945,008,000 JPY
3,878,829,000 JPY
3,167,410,000 JPY
Extraordinary income
Extraordinary income
29,224,000 JPY
27,924,000 JPY
292,204,000 JPY
290,504,000 JPY
Extraordinary losses
Extraordinary losses
10,187,000 JPY
9,894,000 JPY
285,830,000 JPY
285,814,000 JPY
Profit (loss) before income taxes
4,263,065,000 JPY
3,963,038,000 JPY
3,885,202,000 JPY
3,172,099,000 JPY
Income taxes - current
1,408,557,000 JPY
1,256,000,000 JPY
1,405,768,000 JPY
1,132,000,000 JPY
Income taxes - deferred
-157,941,000 JPY
-178,039,000 JPY
-147,582,000 JPY
-116,425,000 JPY
Profit (loss)
2,885,078,000 JPY
3,012,450,000 JPY
2,885,078,000 JPY
2,885,078,000 JPY
2,885,078,000 JPY
2,156,524,000 JPY
2,156,524,000 JPY
2,156,524,000 JPY
2,627,016,000 JPY
2,156,524,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.